Exelixis Announces the Discovery of Two Proteins Involved in Alzheimer’s Disease
Discovery Could Lead to New Therapeutic Approaches to CNS Disorders
09-Jul-2002 -
SOUTH SAN FRANCISCO, Calif. July 8, 2002
Scientists at Exelixis, Inc., working in collaboration with Pharmacia Corporation have discovered two proteins that play a role in the production of beta-amyloid, the main constituent of senile plaques associated with Alzheimer’s disease. aph-1 and pen-2 ...
CNS disorders
functional genomics
genetics
+6